Literature DB >> 2372233

Identification of antiarrhythmic drugs and their metabolites in urine.

H H Maurer1.   

Abstract

Identification of the antiarrhythmic drugs ajmaline, aprindine, diltiazem, disopyramide, flecainide, gallopamil, lidocaine, lorcainide, mexiletine, phenytoin, prajmaline, propafenone, quinidine, sparteine, tocainide and verapamil and their metabolites in urine is described. After acid hydrolysis of the conjugates, extraction and acetylation, the urine samples were analysed by computerized gas chromatography-mass spectrometry. Using ion chromatography with the selective ions m/z 58, 72, 84, 86, 136, 224, 266, and 426, the possible presence of antiarrhythmic drugs and/or their metabolites was indicated. The identity of positive signals in the reconstructed ion chromatograms was confirmed by a visual or computerized comparison of the stored full mass spectra with the reference spectra. The ion chromatograms, reference mass spectra and gas chromatographic retention indices (OV-101) are documented. The method presented is integrated in a general screening procedure (general unknown analysis) for several groups of drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372233     DOI: 10.1007/bf02010728

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  16 in total

1.  Screening procedure for the detection of alkanolamine antihistamines and their metabolites in urine using computerized gas chromatography-mass spectrometry.

Authors:  H Maurer; K Pfleger
Journal:  J Chromatogr       Date:  1988-06-24

2.  Screening for neutral and basic drugs in blood by dual fused-silica column chromatography with nitrogen-phosphorus detection.

Authors:  A Turcant; A Premel-Cabic; A Cailleux; P Allain
Journal:  Clin Chem       Date:  1988-07       Impact factor: 8.327

3.  Testing for basic drugs in biological fluids by solvent extraction and dual capillary GC/NPD.

Authors:  D Fretthold; P Jones; G Sebrosky; I Sunshine
Journal:  J Anal Toxicol       Date:  1986 Jan-Feb       Impact factor: 3.367

4.  Screening procedure for detection of phenothiazine and analogous neuroleptics and their metabolites in urine using a computerized gas chromatographic-mass spectrometric technique.

Authors:  H Maurer; K Pfleger
Journal:  J Chromatogr       Date:  1984-03-09

5.  [Retention indices for gas chromatographic identification of drugs (authors transl)].

Authors:  H Berninger; M R Möller
Journal:  Arch Toxicol       Date:  1977-08-09       Impact factor: 5.153

6.  Identification of phenothiazine antihistamines and their metabolites in urine.

Authors:  H Maurer; K Pfleger
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

7.  Identification and differentiation of beta-blockers and their metabolites in urine by computerized gas chromatography-mass spectrometry.

Authors:  H Maurer; K Pfleger
Journal:  J Chromatogr       Date:  1986-10-31

8.  Screening procedure for detection of antidepressants and their metabolites in urine using a computerized gas chromatographic--mass spectrometric technique.

Authors:  H Maurer; K Pfleger
Journal:  J Chromatogr       Date:  1984-02-10

9.  High-performance liquid chromatographic analysis of basic drugs on silica columns using non-aqueous ionic eluents. II. Application of UV, fluorescence and electrochemical oxidation detection.

Authors:  I Jane; A McKinnon; R J Flanagan
Journal:  J Chromatogr       Date:  1985-04-26

10.  Identification and quantitation of neutral and basic drugs in blood by gas chromatography and mass spectrometry.

Authors:  A Cailleux; A Turcant; A Premel-Cabic; P Allain
Journal:  J Chromatogr Sci       Date:  1981-04       Impact factor: 1.618

View more
  2 in total

1.  Detection of anticonvulsants and their metabolites in urine within a "general unknown" analysis procedure using computerized gas chromatography-mass spectrometry.

Authors:  H H Maurer
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 2.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.